VNDB Stock | News | Quote | Stock Forum | Sunday, October 6,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Vendum Batteries Inc. VNDB Company Overview 

Stock Message Board http://investorshangout.com/search?q=VNDB&...mp;yt1=Go!

Last Updated: Sunday, October 6, 2013 5:11:30 PM

Vendum Batteries Inc. VNDB Current Price and Quotes
Last Price 0.0001
Previous Close 0.0001 Open N/A
Daily Range N/A - N/A 52wk Range 0.0014 - 0.0001
Volume 0 Dividend N/A
Average Vol (3m) 4,817,633 Yield N/A
Vendum Batteries Inc. VNDB
Company Information

400 Thames Valley Park Drive
Reading
Berkshire RG6 1PT
United Kingdom

Website: http://www.vendumbatteries.com
Phone: +44 118 380 0895

Vendum Batteries Inc. VNDB
Vendum Batteries has a pending patent on a non-toxic, carbon-based light-weight battery. The paper-thin battery contains none of the toxic elements used in conventional batteries and its cutting edge carbon nanotube and cellulose-based technology makes it entirely biodegradable. The Vendum Battery will be developed from its current low power capacity, to soon accommodate the ever-increasing global demand for durable battery power for cell phones, iPods, gadgets, human implants and eventually el...



Vendum Batteries Inc. VNDB
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2012 10-Q
CIK 0001426568
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data

SIC - Industry Classification 2721 - Periodicals
Business Status Development Stage Company a/o Feb 29, 2008
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Glenn Tellier CEO, CFO, President
Company Directors

Not Available
Company Notes

Formerly=Wishart Enterprises Ltd. until 6-2010
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Morningstar Corporate Communications

Vendum Batteries Inc. VNDB
VNDB Security Details

Share Structure

Market Value1 $74,995 a/o Oct 04, 2013
Shares Outstanding 749,948,317 a/o Nov 16, 2012
Float Not Available
Authorized Shares 750,000,000 a/o Feb 02, 2011
Par Value  0.001
Shareholders

Shareholders of Record 15 a/o Apr 20, 2012
Security Notes

Capital Change=shs increased by 31.229774 for 1 split, payable upon surrender. Pay date=12/05/2008.
Capital Change=shs increased by 2.797928067116027 for 1 split, payable upon surrender. Pay date=06/04/2010.
Capital Change=shs increased by 5 for 1 split payable upon surrender.. Pay date=12/06/2010.
Short Selling Data

Short Interest 0 (-100%)
May 31, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Empire Stock Transfer Inc.

Vendum Batteries Inc. VNDB Recent News

Vendum Batteries Inc. VNDB Financials

VNDB Vendum Batteries Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=VNDB&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/VNDB/quote
Stock Chart http://www.otcmarkets.com/stock/VNDB/chart
Company Info http://www.otcmarkets.com/stock/VNDB/company-info
Recent News http://www.otcmarkets.com/stock/VNDB/news
Financials http://www.otcmarkets.com/stock/VNDB/financials
Filings and Disclosure http://www.otcmarkets.com/stock/VNDB/filings
Short Sales http://www.otcmarkets.com/stock/VNDB/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/VNDB/insider-transactions
Research Reports http://www.otcmarkets.com/stock/VNDB/research
Summary http://finance.yahoo.com/q?s=VNDB
Historical Prices http://finance.yahoo.com/q/hp?s=VNDB+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=VNDB
Basic Chart http://finance.yahoo.com/q/bc?s=VNDB+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=VNDB+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=VNDB+Headlines
Press Releases http://finance.yahoo.com/q/p?s=VNDB+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=VNDB+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=VNDB+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=VNDB+Industry
Major Holders http://finance.yahoo.com/q/mh?s=VNDB+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=VNDB+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=VNDB+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=VNDB
Balance Sheet http://finance.yahoo.com/q/bs?s=VNDB
Cash Flow http://finance.yahoo.com/q/cf?s=VNDB+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/VNDB
Market Watch http://www.marketwatch.com/investing/stock/VNDB
Bloomberg http://www.bloomberg.com/quote/VNDB:US
Morningstar http://quotes.morningstar.com/stock/s?t=VNDB
Bussinessweek http://investing.businessweek.com/research/st...icker=VNDB
Barchart http://www.barchart.com/quotes/stocks/VNDB
OTC Short Report http://otcshortreport.com/index.php?index=VNDB
Investopedia http://www.investopedia.com/markets/stocks/VNDB/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kinross Gold Fraud Lawsuit: What Shareholders Need to Know

Updated Category News Views 18

Kinross Gold's Legal Quagmire There's a fresh storm brewing for Kinross Gold Corporation (NYSE: KGC), and it ain't the kind investors enjoy riding. You see, the company is up to its neck in a class action lawsuit, courtesy of Schall, Brown & Schwartz LLP—a big-name shareholder rights litigation outfit. The gripe? Alleged securities fraud, violating §§10(b) and 20(a)...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Keiki Smiles Boosts Pediatric Dental Care in Waipahu

Updated Category News Views 76

A Neighborhood Dentists' Big Move: Keiki Smiles Expands in Waipahu Well, if there's one thing the dentists of Waipahu know how to do, it's adapt and grow. Keiki Smiles of Leeward, a trusted name in pediatric dentistry, just set up shop at a fresh location. The move marks a new chapter for this community staple, and honestly, it's miles more than just a longer lease and a...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 71

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Inventor Launches Handy Solution for Kids' Car Sickness

Updated Category News Views 5

A Fresh Take on an Age-Old Problem Just when you thought the universe had thrown all it could at beleaguered parents, here comes a nifty little accessory tackling those dreaded uphill battles with kids and car rides. Some bright spark from Middleburgh, New York, sick of scrubbing car seats and clothing every other road trip, came up with a clever little invention named...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 73

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 201

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
Life Insurance: Evolving with Your Financial Journey

Updated Category News Views 56

Why Life Insurance Isn't Just a 'Set It and Forget It' Life insurance isn't some one-time deal you lock in and toss aside. Mike Newell, an insurance pro, highlights how life's shifts—whether in income, dependents, or debt—should drive tweaks to your coverage. As your life story unfolds, so too should the backbone of your financial security. Early Adulthood: Setting...

Continue Reading
AppLovin Faces Legal Heat: Investors on Edge Today

Updated Category News Views 43

AppLovin's Day of Reckoning: Investors Take Note Ever find yourself caught in a whirlwind of corporate promises that slide into disappointment? Well, buckle up, because that's exactly where AppLovin finds itself today. They've stirred up a storm with investors over some questionable hyperbole about their artificial intelligence tools and ad services. Missteps and Market...

Continue Reading
Radiate Holdco's Q3 Results: What We Know Now

Updated Category News Views 16

Digging Into Third Quarter Highlights Radiate Holdco, LLC has just thrown its third-quarter financial hat into the ring, stirring up some interest in the world of FLFO secured notes and senior notes. The folks in Princeton, N.J., sure know how to keep things exclusive—this intel is only for those holding their Notes or in the pretty exclusive club of qualified...

Continue Reading

Top 5 Most Recently Viewed Articles

Aptiv Plans Strategic Split to Strengthen Innovation and Growth

Updated Category News Views 783

Aptiv's Transformative Separation Announcement Aptiv PLC (NYSE: APTV), a pioneering technology company focused on creating a safer and more connected future, has officially unveiled plans to separate its Electrical Distribution Systems (EDS) business. This strategic decision, unanimously approved by the Board of Directors, sets the stage for both Aptiv and EDS to operate...

Continue Reading
e& Reports Strong Q3 2025 with Record Revenue and Growth

Updated Category News Views 364

Impressive Growth for e& in Q3 2025 e& has unveiled its Q3 2025 financial summary, showcasing robust growth with consolidated revenues soaring to AED 18.6 billion. This marks an impressive year-over-year growth of 29.2%. The momentum isn't just limited to the quarter; for the first nine months of 2025, the company reported consolidated revenues of AED 53.5 billion,...

Continue Reading
PARRIS Law Firm Achieves Prestigious Trial Awards for 2024 Success

Updated Category News Views 242

Acknowledging PARRIS Law Firm's Impressive Recognition in 2024 PARRIS Law Firm, renowned for its excellence in trial advocacy, has just earned multiple accolades from Top Verdict for its remarkable performances in 2024. With several No. 1 verdicts in various categories, this year marks another milestone for the firm as it stands tall among California's premier legal...

Continue Reading
Insights into the Latest Riksbank Certificate Auction Results

Updated Category News Views 232

Overview of the Riksbank Certificate Auction The recent auction conducted by the Riksbank has revealed significant details regarding certificate sales that are vital for investors and market analysts. The auction concluded successfully, showcasing the Riksbank's strategies and market engagement. Auction Details and Financial Impact Key Dates and Interest Rates The auction...

Continue Reading
Alamar Biosciences Unveils Advanced NULISAqpcr Custom Assay Kit

Updated Category News Views 205

Alamar Biosciences Introduces the NULISAqpcr™ Custom Assay Development Kit Alamar Biosciences has unveiled a significant innovation in the field of precision proteomics with the launch of the NULISAqpcr™ Custom Assay Development Kit. This groundbreaking product allows researchers to develop highly sensitive biomarker assays tailored to their specific research needs....

Continue Reading